References

1. Grønborg, T.K.; Schendel, D.E.; Parner, E.T. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: A population-based cohort study. JAMA Pediatr. 2013, 167, 947–953.Orly Weissberg; Evan Elliott; The Mechanisms of CHD8 in Neurodevelopment and Autism Spectrum Disorders. Genes 2021, 12, 1133, 10.3390/genes12081133.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th ed.; The American Psychiatric Association: Washington, DC, USA, 2014; Volume 11, ISBN 01679236 (ISSN).
3. Krumm, N.; Turner, T.N.; Baker, C.; Vives, L.; Mohajeri, K.; Witherspoon, K.; Raja, A.; Coe, B.P.; Stessman, H.A.; He, Z.X.; et al. Excess of rare, inherited truncating mutations in autism. Nat. Genet. 2015, 47, 582–588.
4. Almandil, N.B.; Alkuroud, D.N.; Abdulazeez, S.; Alsulaiman, A.; Elaissari, A.; Francis Borgio, J. Environmental and Genetic Factors in Autism Spectrum Disorders: Special Emphasis on Data from Arabian Studies. Int. J. Environ. Res. Public Health 2019, 16, 658.
5. Chen, Y.; Liu, S.; Xu, H.; Zheng, H.; Bai, C.; Pan, W.; Zhou, H.; Liao, M.; Huang, C.; Dong, Q. Maternal exposure to low dose BDE209 and Pb mixture induced neurobehavioral anomalies in C57BL/6 male offspring. Toxicology 2019, 418, 70–80.
6. Maenner, M.J.; Shaw, K.A.; Baio, J.; Washington, A.; Patrick, M.; DiRienzo, M.; Christensen, D.L.; Wiggins, L.D.; Pettygrove, S.; Andrews, J.G.; et al. Prevalence of autism spectrum disorder among children aged 8 Years-Autism and developmental disabilities monitoring network, 11 Sites, United States, 2016. MMWR Surveill. Summ. 2020, 69, 1–12.
7. Leigh, J.P.; Du, J. Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States. J. Autism Dev. Disord. 2015, 45, 4135–4139.
8. Autism Statistics 2020: Is Autism an Epidemic? SingleCare. Available online: https://www.singlecare.com/blog/news/autism-statistics/ (accessed on 19 November 2020).
9. Wing, L.; Gould, J. Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classification. J. Autism Dev. Disord. 1979, 9, 11–29.
10. Leary, M.R.; Hill, D.A. Moving on: Autism and movement disturbance. Ment. Retard. 1996, 34, 39–53.
11. Shibutani, M.; Horii, T.; Shoji, H.; Morita, S.; Kimura, M.; Terawaki, N.; Miyakawa, T.; Hatada, I. Arid1b haploinsufficiency causes abnormal brain gene expression and autism-related behaviors in mice. Int. J. Mol. Sci. 2017, 18, 1872.
12. Howsmon, D.P.; Kruger, U.; Melnyk, S.; James, S.J.; Hahn, J. Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation. PLoS Comput. Biol. 2017, 13, e1005385.
13. Chaidez, V.; Hansen, R.L.; Hertz-Picciotto, I. Gastrointestinal problems in children with autism, developmental delays or typical development. J. Autism Dev. Disord. 2014, 44, 1117–1127.
14. Lord, C.; Brugha, T.; Charman, T.; Cusack, J.; Dumas, G.; Frazier, T.; Jones, E.; Jones, R.; Pickles, A.; State, M. Autism Spectrum Disorder. In Nature Reviews Disease Primers; Nature Publishing Group: London, UK, 2020; Volume 6, p. 5. ISBN 9780128093245.
15. Kang, D.W.; Adams, J.B.; Gregory, A.C.; Borody, T.; Chittick, L.; Fasano, A.; Khoruts, A.; Geis, E.; Maldonado, J.; McDonough-Means, S.; et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome 2017, 5, 10.
16. Bakheet, S.A.; Alzahrani, M.Z.; Ansari, M.A.; Nadeem, A.; Zoheir, K.M.A.; Attia, S.M.; Al-Ayadhi, L.Y.; Ahmad, S.F. Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism. Mol. Neurobiol. 2017, 54, 5201–5212.
17. Varghese, M.; Keshav, N.; Jacot-Descombes, S.; Warda, T.; Wicinski, B.; Dickstein, D.L.; Harony-Nicolas, H.; De Rubeis, S.; Drapeau, E.; Buxbaum, J.D.; et al. Autism spectrum disorder: Neuropathology and animal models. Acta Neuropathol. 2017, 134, 537–566.
18. Li, Y.J.; Zhang, X.; Li, Y.M. Antineuroinflammatory therapy: Potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function. CNS Spectr. 2019, 25, 493–501.
19. Zamberletti, E.; Gabaglio, M.; Woolley-Roberts, M.; Bingham, S.; Rubino, T.; Parolaro, D. Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats. Front. Cell. Neurosci. 2019, 13, 367.
20. Rose, D.R.; Yang, H.; Serena, G.; Sturgeon, C.; Ma, B.; Careaga, M.; Hughes, H.K.; Angkustsiri, K.; Rose, M.; Hertz-Picciotto, I.; et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain. Behav. Immun. 2018, 70, 354–368.
21. O’Roak, B.J.; Vives, L.; Girirajan, S.; Karakoc, E.; Krumm, N.; Coe, B.P.; Levy, R.; Ko, A.; Lee, C.; Smith, J.D.; et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485, 246–250.
22. Katayama, Y.; Nishiyama, M.; Shoji, H.; Ohkawa, Y.; Kawamura, A.; Sato, T.; Suyama, M.; Takumi, T.; Miyakawa, T.; Nakayama, K.I. CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nat. Publ. Gr. 2016, 537, 675–679.
23. Bernier, R.; Golzio, C.; Xiong, B.; Stessman, H.A.; Coe, B.P.; Penn, O.; Witherspoon, K.; Gerdts, J.; Baker, C.; Vulto-Van Silfhout, A.T.; et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 2014, 158, 263–276.
24. Talkowski, M.E.; Rosenfeld, J.A.; Blumenthal, I.; Pillalamarri, V.; Chiang, C.; Heilbut, A.; Ernst, C.; Hanscom, C.; Rossin, E.; Lindgren, A.M.; et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012, 149, 525–537.
25. Blumenthal, I.; Ragavendran, A.; Erdin, S.; Klei, L.; Sugathan, A.; Guide, J.R.; Manavalan, P.; Zhou, J.Q.; Wheeler, V.C.; Levin, J.Z.; et al. Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex and multiplex autism families. Am. J. Hum. Genet. 2014, 94, 870–883.
26. Wade, A.A.; Lim, K.; Catta-Preta, R.; Nord, A.S. Common CHD8 genomic targets contrast with model-specific transcriptional impacts of CHD8 haploinsufficiency. Front. Mol. Neurosci. 2019, 11, 481.
27. Jiménez, J.A.; Ptacek, T.S.; Tuttle, A.H.; Schmid, R.S.; Moy, S.S.; Simon, J.M.; Zylka, M.J. Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life. Mol. Autism 2020, 11, 1–15.
28. Wilkinson, B.; Grepo, N.; Thompson, B.L.; Kim, J.; Wang, K.; Evgrafov, O.V.; Lu, W.; Knowles, J.A.; Campbell, D.B. The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes. Transl. Psychiatry 2015, 5, e568.
29. O’Roak, B.J.; Vives, L.; Fu, W.; Egertson, J.D.; Stanaway, I.B.; Phelps, I.G.; Carvill, G.; Kumar, A.; Lee, C.; Ankenman, K.; et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338, 1619–1622.
30. Li, J.; Wang, L.; Guo, H.; Shi, L.; Zhang, K.; Tang, M.; Hu, S.; Dong, S.; Liu, Y.; Wang, T.; et al. Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders. Mol. Psychiatry 2017, 22, 1282–1290.
31. Douzgou, S.; Liang, H.W.; Metcalfe, K.; Somarathi, S.; Tischkowitz, M.; Mohamed, W.; Kini, U.; McKee, S.; Yates, L.; Bertoli, M.; et al. The clinical presentation caused by truncating CHD8 variants. Clin. Genet. 2019, 96, 72–84.
32. Ostrowski, P.J.; Zachariou, A.; Loveday, C.; Beleza-Meireles, A.; Bertoli, M.; Dean, J.; Douglas, A.G.L.; Ellis, I.; Foster, A.; Graham, J.M.; et al. The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients. Am. J. Med. Genet. Part C Semin. Med. Genet. 2019, 181, 557–564.
33. An, Y.; Zhang, L.; Liu, W.; Jiang, Y.; Chen, X.; Lan, X.; Li, G.; Hang, Q.; Wang, J.; Gusella, J.F.; et al. De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth. Hum. Genet. 2020, 139, 499–512.
34. Wang, T.; Guo, H.; Xiong, B.; Stessman, H.A.F.; Wu, H.; Coe, B.P.; Turner, T.N.; Liu, Y.; Zhao, W.; Hoekzema, K.; et al. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat. Commun. 2016, 7, 13316.
35. Yasin, H.; Gibson, W.T.; Langlois, S.; Stowe, R.M.; Tsang, E.S.; Lee, L.; Poon, J.; Tran, G.; Tyson, C.; Wong, C.K.; et al. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. J. Hum. Genet. 2019, 64, 271–280.
36. Stolerman, E.S.; Smith, B.; Chaubey, A.; Jones, J.R. CHD8 intragenic deletion associated with autism spectrum disorder. Eur. J. Med. Genet. 2016, 59, 189–194.
37. Thompson, B.A.; Tremblay, V.; Lin, G.; Bochar, D.A. CHD8 Is an ATP-Dependent Chromatin Remodeling Factor That Regulates β-Catenin Target Genes. Mol. Cell. Biol. 2008, 28, 3894–3904.
38. Nishiyama, M.; Oshikawa, K.; Tsukada, Y.-I.; Nakagawa, T.; Iemura, S.-I.; Natsume, T.; Fan, Y.; Kikuchi, A.; Skoultchi, A.I.; Nakayama, K.I. CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat. Cell Biol. 2009, 11, 172–182.
39. Manning, B.J.; Yusufzai, T. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities. J. Biol. Chem. 2017, 292, 11927–11936.
40. Nishiyama, M.; Skoultchi, A.I.; Nakayama, K.I. Histone H1 Recruitment by CHD8 Is Essential for Suppression of the Wnt-Catenin Signaling Pathway. Mol. Cell. Biol. 2012, 3, 501–512.
41. Subtil-Rodríguez, A.; Vázquez-Chávez, E.; Ceballos-Chávez, M.; Rodríguez-Paredes, M.; Martín-Subero, J.I.; Esteller, M.; Reyes, J.C. The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes. Nucleic Acids Res. 2014, 42, 2185–2196.
42. Ishihara, K.; Oshimura, M.; Nakao, M. CTCF-Dependent Chromatin Insulator Is Linked to Epigenetic Remodeling. Mol. Cell 2006, 23, 733–742.
43. Batsukh, T.; Schulz, Y.; Wolf, S.; Rabe, T.I.; Oellerich, T.; Urlaub, H.; Schaefer, I.M.; Pauli, S. Identification and Characterization of FAM124B as a Novel Component of a CHD7 and CHD8 Containing Complex. PLoS ONE 2012, 7, e52640.
44. Cotney, J.; Muhle, R.A.; Sanders, S.J.; Liu, L.; Willsey, A.J.; Niu, W.; Liu, W.; Klei, L.; Lei, J.; Yin, J.; et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat. Commun. 2015, 6, 6404.
45. Zhao, C.; Dong, C.; Frah, M.; Deng, Y.; Marie, C.; Zhang, F.; Xu, L.; Ma, Z.; Dong, X.; Lin, Y.; et al. Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair. Dev. Cell 2018, 45, 753–768.e8.
46. Goodman, J.V.; Bonni, A. Regulation of neuronal connectivity in the mammalian brain by chromatin remodeling. Curr. Opin. Neurobiol. 2019, 59, 59–68.
47. Durak, O.; Gao, F.; Kaeser-Woo, Y.J.; Rueda, R.; Martorell, A.J.; Nott, A.; Liu, C.Y.; Watson, L.A.; Tsai, L.H. Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling. Nat. Neurosci. 2016, 19, 1477–1488.
48. Sugathan, A.; Biagioli, M.; Golzio, C.; Erdin, S.; Blumenthal, I.; Manavalan, P.; Ragavendran, A.; Brand, H.; Lucente, D.; Miles, J.; et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc. Natl. Acad. Sci. USA 2014, 111, E4468–E4477.
49. Sanders, S.J. First glimpses of the neurobiology of autism spectrum disorder. Curr. Opin. Genet. Dev. 2015, 33, 80–92.
50. Kasah, S.; Oddy, C.; Basson, M.A. Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes. J. Anat. 2018, 233, 755–769.
51. Xu, Q.; Liu, Y.; Wang, X.; Tan, G.; Li, H.; Hulbert, S.W.; Li, C. Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons. Mol. Autism 2018, 9, 65.
52. Jung, H.; Park, H.; Choi, Y.; Kang, H.; Lee, E.; Kweon, H.; Roh, J.D.; Ellegood, J.; Choi, W.; Kang, J.; et al. Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice. Nat. Neurosci. 2018, 21, 1218–1228.
53. Wang, P.; Mokhtari, R.; Pedrosa, E.; Kirschenbaum, M.; Bayrak, C.; Zheng, D.; Lachman, H.M. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol. Autism 2017, 8, 11.
54. Sood, S.; Weber, C.M.; Hodges, H.C.; Krokhotin, A.; Shalizi, A.; Crabtree, G.R. CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation. Proc. Natl. Acad. Sci. USA 2020, 117, 22331–22340.
55. Siu, M.T.; Butcher, D.T.; Turinsky, A.L.; Cytrynbaum, C.; Stavropoulos, D.J.; Walker, S.; Caluseriu, O.; Carter, M.; Lou, Y.; Nicolson, R.; et al. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clin. Epigenetics 2019, 11, 103.
56. Wong, W.R.; Brugman, K.I.; Maher, S.; Oh, J.Y.; Howe, K.; Kato, M.; Sternberg, P.W. Autism-Associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans. Hum. Mol. Genet. 2019, 28, 2271–2281.
57. Genç, Ö.; An, J.Y.; Fetter, R.D.; Kulik, Y.; Zunino, G.; Sanders, S.J.; Davis, G.W. Homeostatic plasticity fails at the intersection of autism-gene mutations and a novel class of common genetic modifiers. Elife 2020, 9, e55775.
58. Coll-Tané, M.; Gong, N.N.; Belfer, S.J.; Renssen, L.v.; Kurtz-Nelson, E.C.; Szuperak, M.; Eidhof, I.; Reijmersdal, B.v.; Terwindt, I.; Verheij, M.M.; et al. The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASDassociated sleep defects. Sci. Adv. 2021, 7, eabe2626.
59. Kita, Y.; Katayama, Y.; Shiraishi, T.; Oka, T.; Sato, T.; Suyama, M.; Ohkawa, Y.; Miyata, K.; Oike, Y.; Shirane, M.; et al. The Autism-Related Protein CHD8 Cooperates with C/EBPβ to Regulate Adipogenesis. Cell Rep. 2018, 23, 1988–2000.
60. Marie, C.; Clavairoly, A.; Frah, M.; Hmidan, H.; Yan, J.; Zhao, C.; Van Steenwinckel, J.; Daveau, R.; Zalc, B.; Hassan, B.; et al. Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. Proc. Natl. Acad. Sci. USA 2018, 115, E8246–E8255.
61. Cherepanov, S.M.; Gerasimenko, M.; Yuhi, T.; Furuhara, K.; Tsuji, C.; Yokoyama, S.; Nakayama, K.I.; Nishiyama, M.; Higashida, H. Oxytocin ameliorates impaired social behavior in a Chd8 haploinsufficiency mouse model of autism. BMC Neurosci. 2021, 22, 32.
62. Platt, R.J.; Zhou, Y.; Slaymaker, I.M.; Shetty, A.S.; Weisbach, N.R.; Kim, J.A.; Sharma, J.; Desai, M.; Sood, S.; Kempton, H.R.; et al. Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. Cell Rep. 2017, 19, 335–350.
63. Gompers, A.L.; Su-Feher, L.; Ellegood, J.; Copping, N.A.; Riyadh, M.A.; Stradleigh, T.W.; Pride, M.C.; Schaffler, M.D.; Wade, A.A.; Catta-Preta, R.; et al. Germline Chd8 haploinsufficiency alters brain development in mouse. Nat. Neurosci. 2017, 20, 1062–1073.
64. Suetterlin, P.; Hurley, S.; Mohan, C.; Riegman, K.L.H.; Pagani, M.; Caruso, A.; Ellegood, J.; Galbusera, A.; Crespo-Enriquez, I.; Michetti, C.; et al. Altered neocortical gene expression, brain overgrowth and functional over-connectivity in chd8 haploinsufficient mice. Cereb. Cortex 2018, 28, 2192–2206.
65. Kawamura, A.; Katayama, Y.; Nishiyama, M.; Shoji, H.; Tokuoka, K.; Ueta, Y.; Miyata, M.; Isa, T.; Miyakawa, T.; Hayashi-Takagi, A.; et al. Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice. Hum. Mol. Genet. 2020, 29, 1274–1291.
66. Hulbert, S.W.; Wang, X.; Gbadegesin, S.O.; Xu, Q.; Xu, X.; Jiang, Y.H. A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination. Autism Res. 2020, 13, 1685–1697.
67. Kawamura, A.; Katayama, Y.; Kakegawa, W.; Ino, D.; Nishiyama, M.; Yuzaki, M.; Nakayama, K.I. The autism-associated protein CHD8 is required for cerebellar development and motor function. Cell Rep. 2021, 35.
68. Phelan, K.; Rogers, R.C.; Boccuto, L. Phelan-McDermid Syndrome. In GeneReviews®; University of Washington: Seattle, WA, USA, 2018.
69. De Rubeis, S.; He, X.; Goldberg, A.P.; Poultney, C.S.; Samocha, K.; Cicek, A.E.; Kou, Y.; Liu, L.; Fromer, M.; Walker, S.; et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515, 209–215.
70. Gregor, A.; Oti, M.; Kouwenhoven, E.N.; Hoyer, J.; Sticht, H.; Ekici, A.B.; Kjaergaard, S.; Rauch, A.; Stunnenberg, H.G.; Uebe, S.; et al. De novo mutations in the genome organizer CTCF cause intellectual disability. Am. J. Hum. Genet. 2013, 93, 124–131.
71. Shingleton, J.R.; Hemann, M.T. The chromatin regulator CHD8 is a context-dependent mediator of cell survival in murine hematopoietic malignancies. PLoS ONE 2015, 10, e0143275.
72. Orly Weissberg; Evan Elliott; The Mechanisms of CHD8 in Neurodevelopment and Autism Spectrum Disorders. Genes 2021, 12, 1133, 10.3390/genes12081133.